ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

In May, Hoth Therapeutics renamed itself Rocket One and pivoted to building AI chips for satellites. The shift occurred two months after auditors raised substantial doubts about the company's ability to stay in business. The stock traded below $1 before the announcement and climbed to nearly $2 afterward.
Tap to vote and see what everyone thinks.
Summary by ByteBrief